What did @biomaxxer actually say?
The creator laid out a multi-compound "anti-aging stack" that included topical retinoids, GHK-Cu peptide, carotenoids, MT2 (melanotan II), NMN, something called "Hidilon" taken intranasally for telomerase activation, and antioxidants like NAD+, glutathione, and high-dose melatonin. The pitch was simple: do all this and "gear will not age you if leveraged correctly."
That last line is doing a lot of work. The stack mixes compounds with legitimate peer-reviewed support, compounds with early but not conclusive evidence, and at least one that is either misspelled beyond recognition or outright made up. The framing is confident in a way the science is not.
A few product names were mangled badly enough to cause real confusion. "Caesaretin" is not a recognized retinoid in dermatology or pharmacology literature. "Beta carotenein" is not standard nomenclature. And "Hidilon" does not correspond to any known peptide, drug, or supplement in indexed databases.
Does the science back this up?
Parts of it, yes. The retinoid claim has decades of support. The GHK-Cu peptide data is genuinely interesting, though mostly in vitro. The carotenoid and antioxidant claims have real but modest evidence. The telomerase claim, however, is where this goes off the rails fast.
Tretinoin (the actual drug name) has strong RCT-level evidence for improving photoaged skin, stimulating collagen synthesis, and increasing epidermal cell turnover (Kang et al., 1995, Journal of the American Academy of Dermatology). GHK-Cu has shown upregulation of collagen and elastin genes in cell culture studies (Pickart and Margolina, 2018, Cosmetics), but human RCT data remains thin. Astaxanthin has demonstrated modest photoprotection in a randomized trial (Tominaga et al., 2012, Acta Biochimica Polonica). NMN does raise NAD+ levels in humans (Yoshino et al., 2021, Science), though whether that translates to measurable anti-aging outcomes in healthy adults is still an open question.
What did they get wrong (or right)?
The telomerase claim is the most problematic. The creator says "optimizing telomerase activity is the best way to keep your chromosomes from degrading," and attributes this to intranasal use of "Hidilon." No such compound exists in the scientific literature under that name. Telomerase activation in humans is also a genuinely double-edged area, because elevated telomerase activity is associated with certain cancers (Shay and Wright, 2011, Nature Reviews Cancer). Presenting this as a straightforward anti-aging intervention is misleading at best and potentially dangerous framing.
MT2 (Melanotan II) being listed as a photoprotective carotenoid is also wrong. MT2 is a synthetic melanocortin receptor agonist, not a carotenoid. It increases melanin production, which can reduce UV sensitivity, but it carries significant cardiovascular and hormonal side effects and is not approved for human use in most countries (Evans-Brown et al., 2009, Drug Testing and Analysis).
Where the creator does earn partial credit: the retinoid framing is directionally correct, the GHK-Cu gene transcription angle is consistent with published mechanisms, and the antioxidant section is reasonable if vague.
What should you actually know?
If you are interested in evidence-based skin aging interventions, the hierarchy of evidence matters. Tretinoin has the strongest human trial data of anything mentioned here. GHK-Cu is promising but not proven at the clinical level yet. NMN is being studied in earnest, but the anti-aging outcomes in healthy humans are not established. High-dose melatonin as an antioxidant has early mechanistic support but no long-term safety data at doses beyond standard sleep doses.
The bigger issue is the stack framing itself. Combining multiple compounds with overlapping mechanisms and unknown interaction profiles is not "biohacking," it is an uncontrolled self-experiment. Anyone considering peptide therapy should be doing so under clinical supervision, with baseline labs and monitoring, not from a 60-second TikTok.
- "Caesaretin" is not a real drug name. The creator likely means tretinoin or possibly trifarotene, but the comparison made here cannot be evaluated because the named compound does not exist in recognized literature.
- "Hidilon" does not appear in PubMed, the Merck Index, or any peptide registry this writer could find. Do not take something you cannot identify.
- MT2 is not a carotenoid and is not approved for cosmetic or therapeutic use in the US, UK, or EU.